Efficacy of tiotropium/olodaterol on lung volume, exercise capacity, and physical activity

References

• BousquetJKhaltaevNGlobal Surveillance, Prevention and Control of Chronic Respiratory Diseases: A Comprehensive ApproachGenevaWorld Health Organisation2007
   Google Scholar
• BarnesPJChronic obstructive pulmonary diseasePreface Clin Chest Med201435113
   Web of Science ®Google Scholar
• WHO [webpage on the Internet]COPD factsheet Published November 2016. Available from: http://www.who.int/mediacentre/factsheets/fs315/en/Accessed October 8, 2017
   Google Scholar
• KimJKimKKimYThe association between inhaled long-acting bronchodilators and less in-hospital care in newly-diagnosed COPD patientsRespir Med2014108115316123993445
   PubMed Web of Science ®Google Scholar
• BuhlRMaltaisFAbrahamsRTiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2–4)Eur Respir J20154596997925573406
   PubMed Web of Science ®Google Scholar
• BeehKMWestermanJKirstenAMThe 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary diseasePulm Pharmacol Ther201532535925956072
   PubMed Web of Science ®Google Scholar
• SinghDFergusonGTBolitschekJTiotropium + olodaterol shows clinically meaningful improvements in quality of lifeRespir Med2015109101312131926320402
   PubMed Web of Science ®Google Scholar
• MaltaisFKirstenAMHamiltonADe SousaDVoßFDecramerMEvaluation of the effects of olodaterol on exercise endurance in patients with chronic obstructive pulmonary disease: results from two 6-week crossover studiesRespir Res20161717727383762
   PubMed Web of Science ®Google Scholar
• O’DonnellDECasaburiRFrithPEffects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPDEur Respir J2017494 pii: 1601348
   Web of Science ®Google Scholar
• BeehKMKornSBeierJEffect of QVA149 on lung volumes and exercise tolerance in COPD patients: the BRIGHT studyRespir Med2014108458459224534204
   PubMed Web of Science ®Google Scholar
• MaltaisFSinghSDonaldACEffects of a combination of umeclidinium/vilanterol on exercise endurance in patients with chronic obstructive pulmonary disease: two randomized, double-blind clinical trialsTher Adv Respir Dis20148616918125452426
   PubMed Web of Science ®Google Scholar
• WatzHTroostersTBeehKMACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPDInt J Chron Obstruct Pulm Dis20171225452558
   PubMed Web of Science ®Google Scholar
• WatzHMailänderCBaierMKirstenAEffects of indacaterol/glycopyrronium (QVA149) on lung hyperinflation and physical activity in patients with moderate to severe COPD: a randomised, placebo-controlled, crossover study (The MOVE Study)BMC Pulm Med20161619527301417
   PubMed Web of Science ®Google Scholar
• IchinoseMMinakataYMotegiTStudy design of VESUTO®: efficacy of tiotropium/olodaterol on lung hyperinflation, exercise capacity, and physical activity in Japanese patients with chronic obstructive pulmonary diseaseAdv Ther20173471622163528537001
   PubMed Web of Science ®Google Scholar
• ByromBRoweDAMeasuring free-living physical activity in COPD patients: deriving methodology standards for clinical trials through a review of research studiesContemp Clin Trials20164717218426806669
   PubMed Web of Science ®Google Scholar
• WatzHPittaFRochesterCLAn official European Respiratory Society statement on physical activity in COPDEur Respir J20144461521153725359358
   PubMed Web of Science ®Google Scholar
• CamilloCALangerDOsadnikCRSurvival after pulmonary rehabilitation in patients with COPD: impact of functional exercise capacity and its changesInt J Chron Obstruct Pulmon Dis2016112671267927822029
   PubMed Web of Science ®Google Scholar
• AndrianopoulosVWoutersEFPinto-PlataVMPrognostic value of variables derived from the six-minute walk test in patients with COPD: results from the ECLIPSE studyRespir Med201510991138114626143282
   PubMed Web of Science ®Google Scholar
• CelliBTetzlaffKCrinerGCOPD Biomarker Qualification ConsortiumThe 6-minute-walk distance test as a chronic obstructive pulmonary disease stratification tool. Insights from the COPD biomarker qualification consortiumAm J Respir Crit Care Med2016194121483149327332504
   PubMed Web of Science ®Google Scholar
• CalzettaLOraJCavalliFRoglianiPO’DonnellDECazzolaMImpact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: a pair-wise and network meta-analysisRespir Med201712918919828732830
   PubMed Web of Science ®Google Scholar
• CasaburiRMaltaisFPorszaszJEffects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary diseaseAnn Am Thorac Soc20141191351136125289942
   PubMedGoogle Scholar
• Puente-MaestuLPalangePCasaburiRUse of exercise testing in the evaluation of interventional efficacy: an official ERS statementEur Respir J201647242946026797036
   PubMed Web of Science ®Google Scholar
• CasaburiRKukafkaDCooperCBWitekTJJrKestenSImprovement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPDChest2005127380981715764761
   PubMed Web of Science ®Google Scholar
• WaatevikMJohannessenAGomez RealFOxygen desaturation in 6-min walk test is a risk factor for adverse outcomes in COPDEur Respir J2016481829127076586
   PubMed Web of Science ®Google Scholar
• VaesAWGarcia-AymerichJMarottJLChanges in physical activity and all-cause mortality in COPDEur Respir J20144451199120925063247
   PubMed Web of Science ®Google Scholar
• WaschkiBKirstenAHolzOPhysical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort studyChest2011140233134221273294
   PubMed Web of Science ®Google Scholar
• Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD)2017 [homepage on the Internet]. Available from: http://goldcopd.orgAccessed October 30, 2017
   Google Scholar
• Committee for the 4th edition of the COPD guidelines of the Japanese Respiratory SocietyGuidelines for the diagnosis and treatment of COPD (chronic obstructive pulmonary disease)4th editionTokyo, JapanThe Japanese Respiratory Society2013 Japanese
   Google Scholar
• MantoaniLCRubioNMcKinstryBMacNeeWRabinovichRAInterventions to modify physical activity in patients with COPD: a systematic reviewEur Respir J2016481698127103381
   PubMed Web of Science ®Google Scholar
• MendozaLHortaPEspinozaJPedometers to enhance physical activity in COPD: a randomised controlled trialEur Respir J201545234735425261324
   PubMed Web of Science ®Google Scholar
• PleguezuelosEPérezMEGuiraoLImproving physical activity in patients with COPD with urban walking circuitsRespir Med2013107121948195623890958
   PubMed Web of Science ®Google Scholar